Core Points - The company announced that it raised a net amount of 1.304 billion yuan through a private placement of shares in 2016, originally intended for investment in the health industry and other projects [1] - In 2022, the company revised part of its project allocations, designating 678 million yuan for the construction of a traditional Chinese medicine production base and 328 million yuan for permanent working capital [1] - The company has previously utilized idle raised funds to purchase financial products or structured deposits, totaling 575 million yuan as of September 30, 2025 [1] - The company plans to continue using no more than 850 million yuan of idle raised funds to purchase related products, with the funds being allowed for rolling use and the authorization valid for one year [1]
新世界:拟用不超8.5亿元闲置募集资金买理财产品或存款